DALLAS, November 20, 2012 /PRNewswire/ -- - RnRMarketResearch.com adds new market research reports "Antithrombotic / Anticoagulant Drugs: Technologies and Global Markets" to its store. This report provides an overview of the global market for antithrombotic/anticoagulant drugs, which is changing due to factors such as an aging population, an increase in thrombotic events, and recent advances in pharmaceuticals. Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017 as well as breakdowns of the market size of anticoagulants by revenue at manufacturers' sales levels, including low molecular weight heparins and oral anticoagulants, as well as breakdowns of antiplatelets and thrombin inhibitors are covered. The research also has a discussion of research and development of antithrombotic/anticoagulant treatments and comprehensive company profiles of top leaders in each of the market segments along with companies that are novel or have specific interest to the field. This report is a comprehensive business tool designed to provide an in-depth look at antithrombotic/anticoagulant drugs market for various cardiovascular applications. The geographic scope of the report is global with a special emphasis on individual regions such as the United States, Europe, Japan and Rest of World. The report describes the industry, its relationship to the healthcare industry and its participants, and trends for the future. Categories discussed in the report include:
All categories are discussed in detail, describing each segment, identifying current products on the market, measuring market size, identifying market drivers, forecasting for 2012 to 2017 and assessing the competitors and competitor market shares. Buy your copy of this report @ http://www.rnrmarketresearch.com/antithrombotic-anticoagulant-drugs-technologies-global-markets-market-report.html. This study is presented to increase the awareness of antithrombotic/ anticoagulant drugs to treat thrombotic disease and other diseases that are linked to thrombotic disease. The study analyzes (1) select antithrombotic/anticoagulant drugs for treating various thrombotic diseases in coronary artery disease, peripheral vascular disease, valvular heart disease, congestive heart failure and many others; (2) the marketing of these drugs in the global market from different standpoints; and (3) the issues and trends affecting the market.